drug

NC410

1 story · latest Aug 13, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by NextCure, Inc.

Timeline

NextCure's NC410-pembrolizumab trial ends after Phase 1b; Part 2 never launched

Aug 13Trial updateMerck & Co., Inc.NC410

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.